Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals granted inducement equity awards to five new non-executive employees on June 15, 2026, under its 2025 Inducement Plan. The awards aggregate 1,397 time-based restricted stock units and were approved by the independent Compensation Committee pursuant to Nasdaq Listing Rule 5635(c)(4).
Key figures
- Rsus granted
- 1397
- New employees
- 5
- Vesting installments
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.